Strategic Capital Advisers, Inc. Eli Lilly & CO Transaction History

Strategic Capital Advisers, Inc.

$121 Million
Q2 2022

A detailed history of Strategic Capital Advisers, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Strategic Capital Advisers, Inc. holds 14,214 shares of LLY stock, worth $12.9 Million. This represents 3.81% of its overall portfolio holdings.

Number of Shares

14,214

Previous 14,059 1.1%

Holding current value

$12.9 Million

Previous $4.03 Million 14.48%

% of portfolio

3.81%

Previous 3.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$278.73 - $327.27 $43,203 - $50,726	155 Added 1.1%	14,214 $4.61 Million
Q1 2022 May 05, 2022	SELL	$234.69 - $291.66 $151,609 - $188,412	-646 Reduced 4.39%	14,059 $4.03 Million
Q4 2021 Jan 19, 2022	BUY	$224.85 - $279.04 $5,846 - $7,255	26 Added 0.18%	14,705 $4.06 Million
Q3 2021 Oct 29, 2021	BUY	$221.6 - $272.71 $240,436 - $295,890	1,085 Added 7.98%	14,679 $3.39 Million
Q2 2021 Jul 30, 2021	SELL	$180.55 - $233.54 $182,174 - $235,641	-1,009 Reduced 6.91%	13,594 $3.12 Million

Q1 2021 Apr 28, 2021	SELL	$164.32 - $212.72 $526,481 - $681,554	-3,204 Reduced 17.99%	14,603 $2.73 Million
Q4 2020 Jan 27, 2021	SELL	$130.46 - $172.63 $12,915 - $17,090	-99 Reduced 0.55%	17,807 $3.01 Million
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $33,045 - $38,223	226 Added 1.28%	17,906 $2.65 Million
Q2 2020 Aug 06, 2020	SELL	$136.42 - $164.18 $198,627 - $239,046	-1,456 Reduced 7.61%	17,680 $2.9 Million
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $13,690 - $16,945	-115 Reduced 0.6%	19,136 $2.65 Million
Q4 2019 Jan 27, 2020	BUY	$106.92 - $132.43 $7,698 - $9,534	72 Added 0.38%	19,251 $2.53 Million
Q3 2019 Nov 05, 2019	SELL	$106.79 - $116.16 $57,025 - $62,029	-534 Reduced 2.71%	19,179 $2.15 Million
Q2 2019 Jul 30, 2019	BUY	$110.79 - $129.32 $1.3 Million - $1.51 Million	11,713 Added 146.41%	19,713 $2.18 Million
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $1.76 Million - $2.07 Million	-15,805 Reduced 66.39%	8,000 $1.04 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $1.16 Million - $1.3 Million	-10,969 Reduced 31.54%	23,805 $2.75 Million
Q3 2018 Oct 29, 2018	BUY	$85.86 - $107.31 $6,954 - $8,692	81 Added 0.23%	34,774 $3.73 Million
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $814,683 - $935,002	10,762 Added 44.97%	34,693 $3.36 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $1.96 Million - $2.1 Million	23,931	23,931 $2.02 Million

Others Institutions Holding LLY

# of Institutions

3,721

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $862B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Capital Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Strategic Capital Advisers, Inc. with notifications on news.

Account

Strategic Capital Advisers, Inc. Eli Lilly & CO Transaction History